OnKure Executives Stack Up Options Ahead of Next Clinical Milestone, Signaling Bullish Confidence in Company’s Future
OnKure insiders buy 330k options, signaling confidence as the company heads toward next clinical milestone – what this means for investors.
3 minutes to read